Adverse Effect Labeling

Adverse Effect Labeling is a regulatory documentation requirement that specifies the systematic disclosure of potential harmful reactions associated with a pharmaceutical product, distinguished by its focus on identifying, characterizing, and communicating clinically significant adverse events in labeling to inform healthcare providers and patients.

9

Publications

419

Citations

46

Authors

26

Institutions

Publications per year

2017–2026

1

Authors

46

  1. JE
    Jill E. Lavigne

    St. John Fisher College, United States

    1 publications · 12 citations

    1

    h-index

  2. GL
    Graham Leese

    Ninewells Hospital, United Kingdom

    1 publications · 149 citations

    1

    h-index

  3. HM
    Helen M. Colhoun

    University of Edinburgh, United Kingdom

    1 publications · 149 citations

    1

    h-index

  4. PG
    Peter Glassman

    VA Greater Los Angeles Healthcare System, United States

    1 publications · 12 citations

    1

    h-index

  5. PW
    Philip W. Smith

    University of Nebraska Medical Center, United States

    1 publications · 25 citations

    1

    h-index

1–5 of 46

Venues

  1. Diabetologia

    1 publications · 149 citations

    1

    h-index

  2. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 16 citations

    1

    h-index

  3. Annals of Pharmacotherapy

    1 publications · 25 citations

    1

    h-index

  4. Journal of Behavioral Decision Making

    1 publications · 66 citations

    1

    h-index

  5. Scientometrics

    1 publications · 65 citations

    1

    h-index

1–5